The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic Applications by Ahmet Murat Aydin, Brittany L. Bunch, Matthew Beatty, Ali Hajiran, Jasreman Dhillon, Amod A. Sarnaik, Amod A. Sarnaik, Shari Pilon-Thomas, Shari Pilon-Thomas, Shari Pilon-Thomas, Michael A. Poch

Get full text

Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system by Rebecca Anne Bekker, Sungjune Kim, Shari Pilon-Thomas, Heiko Enderling

Get full text

Examination of MARCO activity on dendritic cell phenotype and function using a gene knockout mouse. by Hiroshi Komine, Lisa Kuhn, Norimasa Matsushita, James J Mulé, Shari Pilon-Thomas

Get full text

Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function. by Shari Pilon-Thomas, Nadine Nelson, Nasreen Vohra, Maya Jerald, Laura Pendleton, Karoly Szekeres, Tomar Ghansah

Get full text

Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer by Sarah Bazargan, Brittany Bunch, Awino Maureiq E. Ojwang‘, Jamie Blauvelt, Annick Landin, Johannes Ali, Dominique Abrahams, Cheryl Cox, Amy M. Hall, Matthew S. Beatty, Michael Poch, Katarzyna A. Rejniak, Shari Pilon-Thomas, Shari Pilon-Thomas

Get full text

598 Reversal of epigenetic silencing of cGAS and STING in melanoma enhances the activity of tumor infiltrating lymphocytes by Shari Pilon-Thomas, Anders Berglund, James Mule, Rana Falahat, Patricio Perez- Villarroel, Ryan Putney, Glen Barber

Intralesional injection of rose bengal induces a systemic tumor-specific immune response in murine models of melanoma and breast cancer. by Paul Toomey, Krithika Kodumudi, Amy Weber, Lisa Kuhn, Ellen Moore, Amod A Sarnaik, Shari Pilon-Thomas

Get full text

Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy. by Krithika N Kodumudi, Jessica Siegel, Amy M Weber, Ellen Scott, Amod A Sarnaik, Shari Pilon-Thomas

Get full text

345 Targeting acidity in bladder cancer to enhance efficacy of adoptive cell therapy (ACT) with tumor reactive T cells by Amy Hall, Shari Pilon-Thomas, Matthew Beatty, Michael Poch, Jamie Blauvelt, Sarah Bazargan, Katarzyna A Rejniak

380 Exploring the microenvironment of clear cell renal cell carcinoma to improve therapy with tumor infiltrating lymphocytes by Shari Pilon-Thomas, Jad Chahoud, Matthew Beatty, Michael I Carter, Fatema Khambati, Marine Potez, Mohammed Alkhouli, Johannes Ali

T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma model. by Hao Liu, Amy Weber, Jennifer Morse, Krithika Kodumudi, Ellen Scott, John Mullinax, Amod A Sarnaik, Shari Pilon-Thomas

Get full text

195 Stimulation of tumor infiltrating B-cells improves ex-vivo TIL expansion for melanoma immunotherapy by Shari Pilon-Thomas, Daniel Abate-Daga, Amod Sarnaik, Dongliang Du, Matthew Beatty, Renata Rossetti, Leticia Tordesillas, Yian Ann Chen

585 Intralesional injection of rose bengal improves the efficacy of gemcitabine chemotherapy against pancreatic cancer by Jennifer Morse, Shari Pilon-Thomas, John Mullinax, Patrick Innamarato, Sarah Asby, Amy Mackay, Matthew Beatty, Jaime Blauvelt, Scott Kidd

Rethinking the immunotherapy numbers game by Shari Pilon-Thomas, Patrick Hwu, Rebecca A Bekker, Mohammad U Zahid, Jennifer M Binning, Bryan Q Spring, Heiko Enderling

Get full text

Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis. by Nadine Nelson, Shengyan Xiang, Xiaohong Zhang, Danielle Gilvary, Julie Djeu, Kazim Husain, Mokenge Malafa, Nasreen Vohra, Shari Pilon-Thomas, Tomar Ghansah

Get full text

Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy. by Jessica Ann Chacon, Richard C Wu, Pariya Sukhumalchandra, Jeffrey J Molldrem, Amod Sarnaik, Shari Pilon-Thomas, Jeffrey Weber, Patrick Hwu, Laszlo Radvanyi

Get full text

Epigenetic state determines the in vivo efficacy of STING agonist therapy by Rana Falahat, Anders Berglund, Patricio Perez-Villarroel, Ryan M. Putney, Imene Hamaidi, Sungjune Kim, Shari Pilon-Thomas, Glen N. Barber, James J. Mulé

Get full text

346 Expansion and identification of neoantigen reactive tumor infiltrating lymphocytes (TIL) from metastatic colorectal (CRC) and GI cancers by Amy Hall, Shari Pilon-Thomas, MacLean Hall, Jason Fleming, Jamie Teer, Matthew Beatty, Larissa Pikor, Barbara Sennino, Madeline Rodriguez-Valentin, Timothy J Langer, Fatema Khambati

Long-Term CD4⁺ T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort Study by Corey Gallen, Christopher W. Dukes, Amy Aldrich, Lauren Macaisa, Qianxing Mo, Christopher L. Cubitt, Shari Pilon-Thomas, Anna R. Giuliano, Brian J. Czerniecki, Ricardo L. B. Costa

Get full text

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma by John E. Mullinax, John E. Mullinax, MacLean Hall, Sangeetha Prabhakaran, Jeffrey Weber, Nikhil Khushalani, Zeynep Eroglu, Andrew S. Brohl, Andrew S. Brohl, Joseph Markowitz, Joseph Markowitz, Erica Royster, Allison Richards, Valerie Stark, Jonathan S. Zager, Jonathan S. Zager, Linda Kelley, Cheryl Cox, Vernon K. Sondak, James J. Mulé, James J. Mulé, Shari Pilon-Thomas, Shari Pilon-Thomas, Amod A. Sarnaik, Amod A. Sarnaik

Get full text